TCTR20210523002CompletedPhase 4
SARS-CoV-2-specific immune responses after COVID-19 vaccination in solid organ transplant recipients
Faculty of Medicine Ramathibodi Hospital0 sites250 target enrollmentStarted: May 23, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 250
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to 99 Years (—)
- Sex
- All
Inclusion Criteria
- •All adult kidney, liver, heart transplant recipients
Exclusion Criteria
- •Active infection or allograft dysfunction
- •Previous COVID-19 vaccination
- •Allergic to COVID-19 vaccine
- •Previous COVID-19 infection
Investigators
Similar Trials
Completed
Phase 4
SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipientsCOVID-19renal transplant, immunogenicity, safety, humoral immunity, cell-mediated immunityTCTR20210524002Faculty of Medicine Ramathibodi Hospital, Mahidol University120
Not yet recruiting
Not Applicable
Humoral immune responses after receiving COVID-19 vaccination in cirrhotic patients.CirrhosisvaccinationCOVID-19cirrhosis, vaccination, COVID-19, CoronaVac, AstraZeneca, SARS-CoV-2 vaccine.TCTR20210622002Faculty of Medicine, Prince of Songla University100
Completed
Unknown
Monitoring of immune responses following COVID-19 infection or vaccination in Bobo-Dioulasso, Burkina FasoCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN41192701Institut National de Santé Publique du Burkina Faso201
Completed
Not Applicable
Immune response to COVID-19 vaccination in patients with autoimmune disorders on various types of immunosuppressive treatmentsImmune response to COVID-19 (SARS-CoV-2 infection) vaccination in patients on immunosuppressive therapyInfections and InfestationsISRCTN68832164Charles University199
Active, not recruiting
Phase 1
Impact of the immune system on response to COVID-19 vaccine in allogeneic stem cell recipientsAllogeneic hematopoietic stem cell recipientsEUCTR2021-000673-83-BECHU de Liège70